Where does Zimmer Biomet Spine, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zimmer Biomet Spine, Inc. ranks #3,795 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zimmer Biomet Spine, Inc. hold?

Zimmer Biomet Spine, Inc. holds 96 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Zimmer Biomet Spine, Inc.'s Innovation Score?

Zimmer Biomet Spine, Inc. has an Innovation Score of 42.4 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Zimmer Biomet Spine, Inc. focus on?

Zimmer Biomet Spine, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 88 patents. Grants appear in 5 CPC subclasses total.

Is Zimmer Biomet Spine, Inc.'s patent grant rate increasing or decreasing?

Zimmer Biomet Spine, Inc.'s recent grant velocity is +57% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Zimmer Biomet Spine, Inc.'s patents?

Zimmer Biomet Spine, Inc.'s patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zimmer Biomet Spine, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Zimmer Biomet Spine, Inc.

USPTO PatentsView assignee record - 96 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zimmer ranks #3,795 of 49,997 tracked US assignees by granted-patent volume, with 96 patents across 5 technology areas.

#3,795
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.4/100): 18.5
avg claims per patent: +57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3795 · US Corporation #3,795 · 96 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 96 grants
TOP-DECILE #3,795/49,997
PHOTO-FINISH Vanda Pharmaceuticals
CPC-NARROW A61B · 5 areas
INNOV-PAR 42.4/100
CLAIMS-RICH 18.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vanda Pharmaceuticals Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Auspex Pharmaceuticals · near

42
Piramal Pharma · near

42
QSC · near

42
The Vollrath L L C · near

42
Zimmer Biomet Spine · this assignee

42
3D Lighting… · lowest

7

What this shows Zimmer's Innovation Score is 42.4/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Zimmer's grants concentrate

Zimmer Biomet Spine, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 91.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (13 grants) versus a trough of 5 in 2016. By volume, Zimmer sits between Vanda Pharmaceuticals Inc. and Cabot Microelectronics Corporation.

Zimmer's three-year grant acceleration

From 2019–2021 to 2022–2024, Zimmer Biomet Spine, Inc. moved from 31 to 35 grants (1.13x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Vanda Pharmaceuti…

96
Verifone

96
Wi-lan

96
Wix com

96
Zimmer Biomet Spi… ◀

96
American Airlines

95
Abbott Molecular

95
Beijing Roborock…

95
Cabot Microelectr…

95

What this shows Zimmer holds 96 patents at rank #3,795, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zimmer

By rank, the assignees closest to #3,795 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Zimmer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zimmer, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (42 here).

The Vollrath Company, L.L.C. 42 Auspex Pharmaceuticals, Inc. 42 QSC, LLC 42 Piramal Pharma Limited 42

Similar claim depth

Nearest assignees by average claims per patent (18.5 here).

The Western Union Company 18.5 avg Baylor University 18.5 avg KPN Innovations LLC 18.5 avg Tyco Electronics Co., Ltd 18.5 avg

Zimmer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Zimmer Biomet Spine, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	5.2%
2017	9	9.4%
2018	10	10.4%
2019	11	11.5%
2020	7	7.3%
2021	13	13.5%
2022	10	10.4%
2023	12	12.5%
2024	13	13.5%
2025partial year	6	6.3%

Which technologies does Zimmer Biomet Spine, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 88

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 31

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 2

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#3,795

of 49,997 tracked assignees

Innovation Score

42.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Zimmer Biomet Spine, Inc.'s patent record in context - here's where to go next.

Zimmer Biomet Spine, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 91.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,795 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zimmer Biomet Spine, Inc. against Vanda Pharmaceuticals Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.